Thomas Brunner

7PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 05, 2026
Reply to: Quality of Chemoradiotherapy in Esophageal Adenocarcinoma Matters.

Thomas B Brunner, Simon Kirste, Claudia Schmoor

|Jul 09, 2025
Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative Chemoradiotherapy.

Jens Hoeppner, Claudia Schmoor, Thomas Brunner

|Jul 12, 2024
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery.

Thomas B Brunner, Judit Boda-Heggemann, Daniel Bürgy

|Feb 25, 2023
The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer.

Richard Partl, Katarzyna Paal, Bettina Stranz

|Feb 11, 2022
125 years of head and neck radiotherapy: could organ-sparing radiotherapy of larynx cancer have prevented World War I?

Thomas B Brunner, Herbert Wördehoff, Ahmed Gawish

Pageof 2